Trade Summary

2 days ago, Neervannan Seshadri, serving as COO at Tarsus Pharmaceuticals, Inc. (TARS), sold 8,366 shares at $76.67 per share, for a total transaction value of $641,421.00. Following this transaction, Neervannan Seshadri now holds 71,292 shares of TARS.

This sale represents a 11.00% decrease in Neervannan Seshadri's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 4, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 1 day after the trade was made.

Tarsus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.